logo
Breadcrumbs Image

Retinal Vein Occlusion Market

Retinal Vein Occlusion Market

Global Retinal Vein Occlusion Market Research Report 2021 Professional Edition


Date: Apr-2021 | Id: MACRC-49014 | Geographical Scope: Global | Publisher: HNY Research

The research team projects that the Retinal Vein Occlusion market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:
Allergan
Novartis
Regeneron Pharmaceuticals
Bayer
IRIDEX Corporation
Bristol-Myers Squibb
Topcon Medical Systems, Inc.
GlaxoSmithKline Plc.
Ellex Medical Lasers
Quantel Medical Inc.
Alimera Sciences
Suzuken Co.Ltd.
ZEISS
Ranbaxy Pharmaceuticals
Fovea Pharmaceuticals SA
Bausch Health
Lumenis
Genentech, Inc.
Icon Biosciences
Sanofi Aventis
Johnson & Johnson Services, Inc.
Annexin Pharmaceuticals AB
Aerpio Therapeutics Inc.
Teva Pharmaceutical, Pfizer Inc.
Astrazeneca

By Type
Branch Retinal Artery Occlusion
Central Retinal Vein Occlusion

By Application
Hospitals and Clinics
Research and Academics
Others

By Regions/Countries:
North America
United States
Canada
Mexico

East Asia
China
Japan
South Korea

Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland

South Asia
India
Pakistan
Bangladesh

Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar

Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman

Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo

Oceania
Australia
New Zealand

South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador

Rest of the World
Kazakhstan

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Retinal Vein Occlusion 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Retinal Vein Occlusion Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Retinal Vein Occlusion Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Retinal Vein Occlusion market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinal Vein Occlusion Revenue
1.4 Market Analysis by Type
1.4.1 Global Retinal Vein Occlusion Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Branch Retinal Artery Occlusion
1.4.3 Central Retinal Vein Occlusion
1.5 Market by Application
1.5.1 Global Retinal Vein Occlusion Market Share by Application: 2022-2027
1.5.2 Hospitals and Clinics
1.5.3 Research and Academics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Retinal Vein Occlusion Market
1.8.1 Global Retinal Vein Occlusion Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Retinal Vein Occlusion Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Retinal Vein Occlusion Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Retinal Vein Occlusion Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Retinal Vein Occlusion Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Retinal Vein Occlusion Sales Volume Market Share by Region (2016-2021)
3.2 Global Retinal Vein Occlusion Sales Revenue Market Share by Region (2016-2021)
3.3 North America Retinal Vein Occlusion Sales Volume
3.3.1 North America Retinal Vein Occlusion Sales Volume Growth Rate (2016-2021)
3.3.2 North America Retinal Vein Occlusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Retinal Vein Occlusion Sales Volume
3.4.1 East Asia Retinal Vein Occlusion Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Retinal Vein Occlusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Retinal Vein Occlusion Sales Volume (2016-2021)
3.5.1 Europe Retinal Vein Occlusion Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Retinal Vein Occlusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Retinal Vein Occlusion Sales Volume (2016-2021)
3.6.1 South Asia Retinal Vein Occlusion Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Retinal Vein Occlusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Retinal Vein Occlusion Sales Volume (2016-2021)
3.7.1 Southeast Asia Retinal Vein Occlusion Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Retinal Vein Occlusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Retinal Vein Occlusion Sales Volume (2016-2021)
3.8.1 Middle East Retinal Vein Occlusion Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Retinal Vein Occlusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Retinal Vein Occlusion Sales Volume (2016-2021)
3.9.1 Africa Retinal Vein Occlusion Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Retinal Vein Occlusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Retinal Vein Occlusion Sales Volume (2016-2021)
3.10.1 Oceania Retinal Vein Occlusion Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Retinal Vein Occlusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Retinal Vein Occlusion Sales Volume (2016-2021)
3.11.1 South America Retinal Vein Occlusion Sales Volume Growth Rate (2016-2021)
3.11.2 South America Retinal Vein Occlusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Retinal Vein Occlusion Sales Volume (2016-2021)
3.12.1 Rest of the World Retinal Vein Occlusion Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Retinal Vein Occlusion Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Retinal Vein Occlusion Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Retinal Vein Occlusion Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Retinal Vein Occlusion Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Retinal Vein Occlusion Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Retinal Vein Occlusion Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Retinal Vein Occlusion Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Retinal Vein Occlusion Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Retinal Vein Occlusion Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Retinal Vein Occlusion Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Retinal Vein Occlusion Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Retinal Vein Occlusion Sales Volume Market Share by Type (2016-2021)
14.2 Global Retinal Vein Occlusion Sales Revenue Market Share by Type (2016-2021)
14.3 Global Retinal Vein Occlusion Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Retinal Vein Occlusion Consumption Volume by Application (2016-2021)
15.2 Global Retinal Vein Occlusion Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Retinal Vein Occlusion Business
16.1 Allergan
16.1.1 Allergan Company Profile
16.1.2 Allergan Retinal Vein Occlusion Product Specification
16.1.3 Allergan Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Novartis
16.2.1 Novartis Company Profile
16.2.2 Novartis Retinal Vein Occlusion Product Specification
16.2.3 Novartis Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Regeneron Pharmaceuticals
16.3.1 Regeneron Pharmaceuticals Company Profile
16.3.2 Regeneron Pharmaceuticals Retinal Vein Occlusion Product Specification
16.3.3 Regeneron Pharmaceuticals Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Bayer
16.4.1 Bayer Company Profile
16.4.2 Bayer Retinal Vein Occlusion Product Specification
16.4.3 Bayer Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 IRIDEX Corporation
16.5.1 IRIDEX Corporation Company Profile
16.5.2 IRIDEX Corporation Retinal Vein Occlusion Product Specification
16.5.3 IRIDEX Corporation Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Bristol-Myers Squibb
16.6.1 Bristol-Myers Squibb Company Profile
16.6.2 Bristol-Myers Squibb Retinal Vein Occlusion Product Specification
16.6.3 Bristol-Myers Squibb Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Topcon Medical Systems, Inc.
16.7.1 Topcon Medical Systems, Inc. Company Profile
16.7.2 Topcon Medical Systems, Inc. Retinal Vein Occlusion Product Specification
16.7.3 Topcon Medical Systems, Inc. Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 GlaxoSmithKline Plc.
16.8.1 GlaxoSmithKline Plc. Company Profile
16.8.2 GlaxoSmithKline Plc. Retinal Vein Occlusion Product Specification
16.8.3 GlaxoSmithKline Plc. Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Ellex Medical Lasers
16.9.1 Ellex Medical Lasers Company Profile
16.9.2 Ellex Medical Lasers Retinal Vein Occlusion Product Specification
16.9.3 Ellex Medical Lasers Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Quantel Medical Inc.
16.10.1 Quantel Medical Inc. Company Profile
16.10.2 Quantel Medical Inc. Retinal Vein Occlusion Product Specification
16.10.3 Quantel Medical Inc. Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Alimera Sciences
16.11.1 Alimera Sciences Company Profile
16.11.2 Alimera Sciences Retinal Vein Occlusion Product Specification
16.11.3 Alimera Sciences Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Suzuken Co.Ltd.
16.12.1 Suzuken Co.Ltd. Company Profile
16.12.2 Suzuken Co.Ltd. Retinal Vein Occlusion Product Specification
16.12.3 Suzuken Co.Ltd. Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 ZEISS
16.13.1 ZEISS Company Profile
16.13.2 ZEISS Retinal Vein Occlusion Product Specification
16.13.3 ZEISS Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Ranbaxy Pharmaceuticals
16.14.1 Ranbaxy Pharmaceuticals Company Profile
16.14.2 Ranbaxy Pharmaceuticals Retinal Vein Occlusion Product Specification
16.14.3 Ranbaxy Pharmaceuticals Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Fovea Pharmaceuticals SA
16.15.1 Fovea Pharmaceuticals SA Company Profile
16.15.2 Fovea Pharmaceuticals SA Retinal Vein Occlusion Product Specification
16.15.3 Fovea Pharmaceuticals SA Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Bausch Health
16.16.1 Bausch Health Company Profile
16.16.2 Bausch Health Retinal Vein Occlusion Product Specification
16.16.3 Bausch Health Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Lumenis
16.17.1 Lumenis Company Profile
16.17.2 Lumenis Retinal Vein Occlusion Product Specification
16.17.3 Lumenis Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Genentech, Inc.
16.18.1 Genentech, Inc. Company Profile
16.18.2 Genentech, Inc. Retinal Vein Occlusion Product Specification
16.18.3 Genentech, Inc. Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.19 Icon Biosciences
16.19.1 Icon Biosciences Company Profile
16.19.2 Icon Biosciences Retinal Vein Occlusion Product Specification
16.19.3 Icon Biosciences Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.20 Sanofi Aventis
16.20.1 Sanofi Aventis Company Profile
16.20.2 Sanofi Aventis Retinal Vein Occlusion Product Specification
16.20.3 Sanofi Aventis Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.21 Johnson & Johnson Services, Inc.
16.21.1 Johnson & Johnson Services, Inc. Company Profile
16.21.2 Johnson & Johnson Services, Inc. Retinal Vein Occlusion Product Specification
16.21.3 Johnson & Johnson Services, Inc. Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.22 Annexin Pharmaceuticals AB
16.22.1 Annexin Pharmaceuticals AB Company Profile
16.22.2 Annexin Pharmaceuticals AB Retinal Vein Occlusion Product Specification
16.22.3 Annexin Pharmaceuticals AB Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.23 Aerpio Therapeutics Inc.
16.23.1 Aerpio Therapeutics Inc. Company Profile
16.23.2 Aerpio Therapeutics Inc. Retinal Vein Occlusion Product Specification
16.23.3 Aerpio Therapeutics Inc. Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.24 Teva Pharmaceutical, Pfizer Inc.
16.24.1 Teva Pharmaceutical, Pfizer Inc. Company Profile
16.24.2 Teva Pharmaceutical, Pfizer Inc. Retinal Vein Occlusion Product Specification
16.24.3 Teva Pharmaceutical, Pfizer Inc. Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.25 Astrazeneca
16.25.1 Astrazeneca Company Profile
16.25.2 Astrazeneca Retinal Vein Occlusion Product Specification
16.25.3 Astrazeneca Retinal Vein Occlusion Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Retinal Vein Occlusion Manufacturing Cost Analysis
17.1 Retinal Vein Occlusion Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Retinal Vein Occlusion
17.4 Retinal Vein Occlusion Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Retinal Vein Occlusion Distributors List
18.3 Retinal Vein Occlusion Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Retinal Vein Occlusion (2022-2027)
20.2 Global Forecasted Revenue of Retinal Vein Occlusion (2022-2027)
20.3 Global Forecasted Price of Retinal Vein Occlusion (2016-2027)
20.4 Global Forecasted Production of Retinal Vein Occlusion by Region (2022-2027)
20.4.1 North America Retinal Vein Occlusion Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Retinal Vein Occlusion Production, Revenue Forecast (2022-2027)
20.4.3 Europe Retinal Vein Occlusion Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Retinal Vein Occlusion Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Retinal Vein Occlusion Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Retinal Vein Occlusion Production, Revenue Forecast (2022-2027)
20.4.7 Africa Retinal Vein Occlusion Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Retinal Vein Occlusion Production, Revenue Forecast (2022-2027)
20.4.9 South America Retinal Vein Occlusion Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Retinal Vein Occlusion Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Retinal Vein Occlusion by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Retinal Vein Occlusion by Country
21.2 East Asia Market Forecasted Consumption of Retinal Vein Occlusion by Country
21.3 Europe Market Forecasted Consumption of Retinal Vein Occlusion by Countriy
21.4 South Asia Forecasted Consumption of Retinal Vein Occlusion by Country
21.5 Southeast Asia Forecasted Consumption of Retinal Vein Occlusion by Country
21.6 Middle East Forecasted Consumption of Retinal Vein Occlusion by Country
21.7 Africa Forecasted Consumption of Retinal Vein Occlusion by Country
21.8 Oceania Forecasted Consumption of Retinal Vein Occlusion by Country
21.9 South America Forecasted Consumption of Retinal Vein Occlusion by Country
21.10 Rest of the world Forecasted Consumption of Retinal Vein Occlusion by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

Add to Cart

Single User

$ 2890.00

Site License

$ 4335.00

Enterprisewide

$ 5780.00